Abstract submission is NOW OPEN through Jan. 31, 2025! Send us your research for possible presentation at the 28th Annual Meeting!
October 22, 2021 | 1 - 3 p.m. (CT)
During this Professional Development Café, we're excited to welcome Ben Kleinstiver, PhD.
Dr. Kleinstiver is a biochemist and genome editor whose interests include translating technologies into molecular medicines. He received his PhD in biochemistry from the University of Western Ontario, and completed his postdoctoral studies at Massachusetts General Hospital and Harvard Medical School.
Within the Center for Genomic Medicine at MGH, the Kleinstiver laboratory seeks to address limitations of CRISPR genome editing technologies while answering important research questions at the forefront of the genome editing field.
ASGCT members & registrants: Watch on demand
January 22-23, 2025 | Virtual
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico